Relay Therapeutics, Inc.
RLAY- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001812364
In the last 90 days, Relay Therapeutics, Inc. insiders filed 0 open-market purchases and 13 sales; 259 institutions reported holding it in 13F filings for Q2 2026, worth $4.58B in total; Duquesne Family Office is the only superinvestor holding it.
13F holders, Q3 2025
Institutional positions in Relay Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 199
- −5 vs. Q2 2025
- Shares held
- 166.2M
- −3.73M (−2.2%) vs. Q2 2025
- Total value
- $867.4M
- +$279.3M (+47.5%) vs. Q2 2025
- New holders
- 20
- 63 more added
- Sold out
- 25
- 63 more reduced
4 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RLAY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 259 | $4.58B |
| Q1 2026 | 244 | $1.83B |
| Q4 2025 | 227 | $1.47B |
| Q3 2025 | 199 | $867.4M |
| Q2 2025 | 208 | $591.8M |
| Q1 2025 | 208 | $438.1M |
| Q4 2024 | 200 | $675.8M |
| Q3 2024 | 195 | $1.16B |
| Q2 2024 | 179 | $826.8M |
| Q1 2024 | 189 | $1.10B |
| Q4 2023 | 177 | $1.40B |
| Q3 2023 | 172 | $1.10B |
| Q2 2023 | 161 | $1.64B |
| Q1 2023 | 157 | $2.16B |
| Q4 2022 | 165 | $1.91B |
| Q3 2022 | 162 | $2.76B |
| Q2 2022 | 148 | $2.02B |
| Q1 2022 | 140 | $3.38B |
| Q4 2021 | 131 | $3.41B |
| Q3 2021 | 132 | $2.89B |
| Q2 2021 | 125 | $3.26B |
| Q1 2021 | 137 | $2.96B |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Relay Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HarbourVest Partners LLC | 0 | $0 | 0.00% | −296,402−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −290,599−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −241,230−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −170,196−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −127,036−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −87,551−100.0% | Sold out |
| OP Asset Management Ltd | 0 | $0 | 0.00% | −70,542−100.0% | Sold out |
| Sanctuary Advisors, LLC | 0 | $0 | 0.00% | −58,654−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −51,698−100.0% | Sold out |
| TrueMark Investments, LLC | 0 | $0 | 0.00% | −49,628−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −39,770−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −38,719−100.0% | Sold out |
| Arkadios Wealth Advisors | 0 | $0 | 0.00% | −25,635−100.0% | Sold out |
| 111 Capital | 0 | $0 | 0.00% | −24,911−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −23,851−100.0% | Sold out |
| Colony Group, LLC | 0 | $0 | 0.00% | −19,647−100.0% | Sold out |
| Zacks Investment Management | 0 | $0 | 0.00% | −15,307−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −15,301−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −13,496−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −11,500−100.0% | Sold out |
| May Hill Capital, LLC | 0 | $0 | 0.00% | −10,914−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −10,320−100.0% | Sold out |
| Highline Wealth Partners LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,984−100.0% | Sold out |
| Norges Bank | – | – | – | – | Not filed |
| Congress Wealth Management LLC | – | – | – | – | Not filed |
| E Fund Management Co., Ltd. | – | – | – | – | Not filed |
| CIBC World Markets Corp | – | – | – | – | Not filed |